drugset / Trial / NCT02576912
Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone
RandomizedCrossoverQuadruple-blindBasic science
Summary
The overall purpose of this study is to examine the effect of pregnenolone (PREG) on the acute psychosis-like and cognitive effects of Delta-9-tetrahydrocannabinol (THC). This will be tested by pretreating healthy individuals with PREG and then assessing their responses to THC.
Timeline
- Start
- 2015-02
- Primary completion
- 2019-06-24
- Completion
- 2019-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dronabinol | Other / unclassified | 0.036 mg/kg | Intravenous |
| Subject | Pregnenolone | Other / unclassified | — | Subcutaneous |
Indications
No indication recorded.